Bill Text: US HB7658 | 2021-2022 | 117th Congress | Introduced


Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7658 Detail]

Download: US_Congress-2021-HB7658-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback